PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...

LONDON, UK, 28 January, 2016 - Skyepharma PLC (LSE SKP), the expert oral and inhalation drug development company, today announces that the Group has entered into agreements with Sanofi Winthrop ...

DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Flutiform" report has been added to ResearchAndMarkets.com's offering. Flutiform ([fluticasone propionate + formoterol fumarate]; ...

Regulatory filing in Europe is expected during the first quarter of 2010. SkyePharma and Mundipharma have reported positive results from a Phase III trial with the inhaled asthma drug combination, ...

- The Mundipharma network of independent associated companies today announces that flutiformk-haler is now available in Europe for adults and adolescents (aged 12 years and older) with asthma where ...

U.K.-based SkyePharma's Flutiform, an inhaled combination of fluticasone and formoterol, has been launched in Germany by the company's partner, Mundipharma, as an asthma maintenance therapy.

The flutiform k-haler takes its name from a unique kinked valve which removes the need for co-ordination, with only gentle inhalation required to trigger the aerosol. Details of the four flutiform ...

The UK’s Skyepharma says that partner Mundipharma has commenced an international clinical trial of the firms’ asthma drug Flutiform for the treatment of chronic obstructive pulmonary disease. The UK’s ...

LONDON, UK, 20 April, 2012 - SkyePharma PLC (LSE SKP) today announces that the Committee for Medicinal Products for Human Use ("CHMP") of the European Medicines Agency ("EMA") has issued a positive ...

- First presentation of largest ever real-world flutiform(R) study at European Respiratory Society International Congress involving over 2,500 patients - Proportion of patients with well-controlled ...

Cambridge, UK, 16 April 2024 – Mundipharma and Vectura will now progress development of the reformulation of flutiform ® (fluticasone propionate/formoterol fumarate) following long-term collaboration, ...

The two companies have entered into a collaboration agreement to continue the development work of incorporating an environmentally friendly propellant into the formulation of flutiform (fluticasone ...